Pacs Group Inc

Pacs Group Inc (PACS) Stock Analysis

$46.910

-0.826 (-1.76%)At close

Loading chart…
High
47.890
Open
47.890
VWAP
47.03
Volume
958.07K
Mkt Cap
—
Low
46.290
Amount
45.06M
EV/EBITDA, TTM
18.70

PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services.

pacs.com

AI analysis of Pacs Group Inc (PACS)

Buy

Pacs Group Inc is a good buy right now, currently priced at $43.30, with a forward P/E ratio of 15.53 indicating potential for growth. The company's recent Q2 earnings showed a revenue increase of 9.1% year-over-year to $1.43 billion, and it raised its full-year revenue guidance to between $5.75 billion and $5.85 billion. The RSI is at 59.50, suggesting it is nearing overbought territory but still has room for growth. The main risk is the recent 20-day change of -3.26%, indicating some volatility, but the overall strong performance and positive analyst sentiment outweigh this risk.

Valuation Metrics

The current forward P/E ratio for Pacs Group Inc (PACS) is 15.53, compared to its 5-year average forward P/E of 12.94.

Forward P/E

Fair
5Y Average P/E
12.94
Current P/E
15.53
Overvalued
18.88
Undervalued
7.00

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
6.35
Current EV/EBITDA
18.70
Overvalued
32.98
Undervalued
-20.29

Forward P/S

Fair
5Y Average P/S
0.83
Current P/S
1.16
Overvalued
1.18
Undervalued
0.47

Whales holding PACS

C

Cohen & Steers Capital Management, Inc.

+ HoldingPACS

-4.97%

3M Return

Events Timeline

2026-10-05 (ET)

05:30:00

Omega Healthcare Transfers 32 Nursing Facilities in Florida, Rent Increases by $26.1M

2026-09-21 (ET)

16:30:00

PACS Group Chief Legal Officer John Mitchell Retires, Patrick J. Murphy to Succeed

2026-09-01 (ET)

16:30:00

Pacs Group Acquires 32 Skilled Nursing Facilities in Florida

2026-08-04 (ET)

17:00:00

Company Reports Q2 Revenue of $1.43B, Exceeding Expectations

17:00:00

Company Raises 2026 Revenue Outlook to $5.75B-$5.85B

News

PACS FAQ — answered by Alphio AI

PACS Group, Inc. is a holding company. The Company, through its subsidiaries, is engaged in providing various skilled nursing facilities (SNF) and assisted living facilities (ALF) services. It provides senior care, assisted living, and independent living options in its communities. It operates 321 post-acute care facilities across 17 states serving over 31,700 patients daily. Its post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. The Company also provides independently operated facilities with technology, support, and back-office services. It operates in the Healthcare sector.

Pacs Group Inc is a good buy right now, currently priced at $43.30, with a forward P/E ratio of 15.53 indicating potential for growth. The company's recent Q2 earnings showed a revenue increase of 9.1% year-over-year to $1.43 billion, and it raised its full-year revenue guidance to between $5.75 billion and $5.85 billion. The RSI is at 59.50, suggesting it is nearing overbought territory but still has room for growth. The main risk is the recent 20-day change of -3.26%, indicating some volatility, but the overall strong performance and positive analyst sentiment outweigh this risk.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading